To read our full disclaimer, click here.
The Clinical Edge has been delivering.
The ideas have performed. The index is tracking well. The thesis-driven approach to healthcare microcaps is working.
Now it’s time to create even more value.
Starting next week, The Clinical Edge is expanding. More ideas, more updates, and an entirely new way to find asymmetric healthcare setups.
What’s New
1. Two Ideas Per Month, Minimum
Same quality. Same depth. Same rigorous framework. Just more of it.
More shots on goal means more optionality across the portfolio. That’s the whole philosophy.
2. Frequent Updates on Every Position
Every company I’ve covered will get ongoing coverage as catalysts hit. Earnings reports, clinical readouts, regulatory decisions, management calls.
When something moves, you’ll hear about it. When a thesis breaks, I’ll be transparent about that too.
The thesis doesn’t end at publication. It’s just the beginning.
3. The Watchlist and Research Pipeline
Every month, subscribers will get a look inside the funnel. What companies I’m currently researching. Where they sit in the pipeline. Which names are closest to becoming a full thesis.
If you see a name on the watchlist and have insights, the chat is open. Some of the best research comes from engaged subscribers who are closer to the ground than I am.
What’s Not Changing
The quality bar. The types of stocks.
Every company still has to clear the same filters: genuine competitive advantages, management with skin in the game, adequate runway to the next catalyst, multiple ways to win, and a market that’s fundamentally mispricing the optionality.
Healthcare microcaps with what I believe to be asymmetric upside. That’s what this page is about.
That’s not going anywhere.
Launch Offer: 25% Off Annual Plans
To mark the relaunch, I’m running a 25% discount on annual subscriptions for the next two weeks.
You get everything: all new theses, all position updates, the quantitative strategy, the watchlist, and full access to the Clinical Edge Index.
If you’re already a subscriber, you’re getting all the additional content at no extra cost. Consider it a thank you for being early.
We’re kicking things off next week with a deep look into the quantitative healthcare strategy. How it works, what it screens for, and what it’s surfacing right now.
Thanks for reading,
Nico
Disclaimer: This is not a recommendation to buy or sell any securities. The Content does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Nothing in this newsletter should be construed as a personal recommendation or advice to buy, sell, or hold any investment or security. All Content is provided for general informational purposes only and should not be relied upon for making investment decisions. You should not make any investment decision based solely on the Content without first consulting with qualified financial advisors, conducting your own research, and considering your individual financial circumstances, investment objectives, and risk tolerance. To read our full disclaimer, click here.


Dear Nico, I only just subscribed to a year within the last 2 weeks. Would you give me the discount please?